Influencing factors and nursing intervention on the compliance to antiviral therapy of patients with hepatitis C

doi:10.3969/j.issn.1006-7795.2015.03.033

Abstract

Abstract:

This article aimed to summarize the influencing factors and nursing intervention on the compliance to antiviral therapy of patients with hepatitis C, to let the medical staff pay more attention to the antiviral treatment adherence for patients with hepatitis C, provide the basis for nursing intervention and health education.

Key words: hepatitis C, antiviral therapy, compliance, influencing factors, nursing intervention

CLC Number:

R575.1

Liu Chen. Influencing factors and nursing intervention on the compliance to antiviral therapy of patients with hepatitis C[J]. Journal of Capital Medical University, 2015, 36(3): 501-504.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2015.03.033

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2015/V36/I3/501

References

[1] Czepiel J, Biesiada G, Mach T. Viral hepatitis C[J]. Pol Arch Med Wewn,2008,118(12):734-740.
[2] Saadeh S, Davis G L. The evolving treatment of chronic hepatitis C: where we stand a decade out[J]. Cleve Clin J Med,2004,71(Suppl 3):S3-7.
[3] Gryseels B, Polman K, Clerinx J, et al. Human schistosomiasis[J]. Lancet,2006,368(9541):1106-1118.
[4] Aman W, Mousa S, Shiha G, et al. Current status and future directions in the management of chronic hepatitis C[J]. Virol J,2012,9:57
[5] Sarasin-Filipowicz M. Interferon therapy of hepatitis C: molecular insights into success and failure[J]. Swiss Med Wkly,2010,140(1-2):3-11.
[6] Di Bisceglie A M, Hoofnagle J H. Optimal therapy of hepatitis C[J]. Hepatology,2002,36(5 Suppl 1):S121-S127.
[7] Seeff L B,Hoofnagle J H. National institutes of health consensus development conference: management of hepatitis C: 2002[J]. Hepatology,2002,36(5 Suppl 1):S1-S2.
[8] Fried M W, Shiffman M L, Reddy K R, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J]. N Engl J Med,2002,347(13):975-982.
[9] Spiegel B M, Younossi Z M, Hays R D, et al. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment[J]. Hepatology,2005,41(4):790-800.
[10] Zeuzem S, Feinman S V, Rasenack J, et al. Peginterferon alfa-2a in patients with chronic hepatitis C[J]. N Engl J Med,2000,343(23):1666-1672.
[11] Lindsay K L, Morishima C, Wright E C, et al. Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C[J]. Clin Gastroenterol Hepatol,2008,6(2):234-241.
[12] Hepatology of Chinese Medical Association. Infectious disease and parasitic disease branch of Chinese medical association. Guidelines for the prevention and treatment of hepatitis C[J]. Chin J Hepatol,2004,12(4):194-198. (In Chinese)
[13] Janke E A, McGraw S, Garcia-Tsao G, et al. Psychosocial issues in hepatitis C: a qualitative analysis[J]. Psychosomatics,2008,49(6):494-501.
[14] Zickmund S, Ho E Y, Masuda M, et al.‘They treated me like a leper’: stigmatization and the qualify of life of patients with hepatitis C[J]. J Gen Intern Med,2003,18(10):835-844.
[15] McHutchison J G, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C[J]. Semin Liver Dis,1999,19 (Suppl 1):57-65.
[16] Kraus M R, Schafer A, Faller H, et al. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy[J]. J Clin Psychiatry,2003,64(6):708-714.
[17] McHutchison J G, Gordon S C, Schiff E R,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group[J]. N Engl J Med,1998, 339(21): 1485-1492.
[18] McHutchison J G, Manns M, Patel K,et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C[J]. Gastroenterology, 2002, 123(4): 1061-1069.
[19] Shi H F,Jiang J D,Li LZ,et al.The research progress of patient compliance[J]. Chin J Nurs, 2003,38(2):134-136.
[20] Hua R, Niu J Q. Pegylated interferon-the best choice for against hepatitis C virus[J]. J Clin Hepatol,2004,20(4):253-254.
[21] Tang H M,Chen F,Yang H Y.Study on the compliance and medication satisfaction in patients receiving antiviral therapy[J].Chinese J Modern Nurs, 2013,19(2):160-162.
[22] Jing X M,Li J R,Meng Q. Adverse reaction and nursing countermeasures in the interferon treatment of chronic hepatitis C[J].J North Sichuan Med Coll, 2001,16(1):69-70.
[23] Miao J, Luo L S. Influence of health education for patients with embolism of hepatic artery[J]. Chin J Pract Nurs, 2007,21(7A):59-60.
[24] Wang F Q,Lin X H,Liu Y W. Study for the correlation of treatment compliance for patients with chronic hepatitis C[J].J Nurs Train, 2009,24(1):13-14.